The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Subclinical Hyperthyroidism Treatment with Herbal Medicine

한약 단독치료로 호전된 불현성 갑상선기능항진증 증례 보고

  • Jin, Dong-eun (Dept. of Internal Medicine, College of Korean Medicine, Daegu Haany University) ;
  • Kim, Seok-woo (Dept. of Internal Medicine, Jaseng Hospital of Korean Medicine) ;
  • Shin, Hyeon-cheol (Dept. of Internal Medicine, College of Korean Medicine, Daegu Haany University)
  • 진동은 (대구한의대학교 한의과대학 내과학교실) ;
  • 김석우 (자생한방병원 한방내과) ;
  • 신현철 (대구한의대학교 한의과대학 내과학교실)
  • Received : 2018.09.01
  • Accepted : 2018.10.02
  • Published : 2018.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study was performed to evaluate the effects of herbal medicine on an elderly patient with subclinical hyperthyroidism who could not use antithyroid medication due to an adverse reaction to methimazole. Methods: Herbal medicine was administered and a thyroid function test was used to evaluate the effects of the treatment. Results: After treatment with herbal medicine and therapy, the patient showed improvements in TSH levels. Conclusion: This case suggested that herbal medicine can be used for patients who have adverse reactions to antithyroid medication; however, additional studies with more patients are required for verification of this finding.

Keywords

References

  1. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291(2):228-38. https://doi.org/10.1001/jama.291.2.228
  2. Kim YA, Park YJ. Prevalence and risk factors of subclinical thyroid disease. Endocrinol Metab (Seoul) 2014;29(1):20-9. https://doi.org/10.3803/EnM.2014.29.1.20
  3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87(2):489-99. https://doi.org/10.1210/jcem.87.2.8182
  4. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012;379(9821):1142-54. https://doi.org/10.1016/S0140-6736(11)60276-6
  5. Abraham-Nordling M, Torring O, Lantz M, Hallengren B, Ohrling H, Lundell G, et al. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. Eur J Endocrinol 2008; 158(6):823-7. https://doi.org/10.1530/EJE-07-0877
  6. Ko KD. Subclinical Thyroid Dysfunction in the Elderly. J Korean Geriatr Soc 2014;18(3):111-21. https://doi.org/10.4235/jkgs.2014.18.3.111
  7. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 2005;152(1):1-9. https://doi.org/10.1530/eje.1.01809
  8. Schlote B, Schaaf L, Schmidt R, Pohl T, Vardarli I, Schiebeler H, et al. Mental and physical state in subclinical hyperthyroidism: investigations in a normal working population. Biol Psychiatry 1992;32(1):48-56. https://doi.org/10.1016/0006-3223(92)90141-L
  9. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 2000; 53(6):733-7. https://doi.org/10.1046/j.1365-2265.2000.01146.x
  10. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001;142(5):838-42. https://doi.org/10.1067/mhj.2001.119370
  11. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000;85(12):4701-5. https://doi.org/10.1210/jc.85.12.4701
  12. Ahn SY, Ahn YM, Lee BC, Lee UJ, Song BK, Jung JC, et al. Kidney Internal medicine Committee of Korean Medicine. Nephro-Endo System in Internal Medicine of Korean Medicine. 2nd edition. Seoul: Koonja publishing company; 2015, p. 89-90, 282-4.
  13. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 2006; 64(3):323-9. https://doi.org/10.1111/j.1365-2265.2006.02464.x
  14. Volzke H, Robinson DM, Schminke U, Ludemann J, Rettig R, Felix SB, et al. Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 2004;89(4):2145-9. https://doi.org/10.1210/jc.2003-031028
  15. Dorr M, Empen K, Robinson DM, Wallaschofski H, Felix SB, Volzke H. The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area. Eur J Endocrinol 2008;159(2):145-52. https://doi.org/10.1530/EJE-08-0140
  16. Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4mIU/l: a prospective study. Clin Endocrinol (Oxf) 2010;72(5):685-8. https://doi.org/10.1111/j.1365-2265.2009.03696.x
  17. Rosario PW. The natural history of subclinical hyperthyroidism in patients below the age of 65 years. Clin Endocrinol (Oxf) 2008;68(3):491-2. https://doi.org/10.1111/j.1365-2265.2007.03030.x
  18. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 2011;96(1):E1-8. https://doi.org/10.1210/jc.2010-0854
  19. Donangelo I, Suh SY. Subclinical Hyperthyroidism: When to Consider Treatment. Am Fam Physician 2017;95(11):710-6.
  20. Cooper DS. The side effects of antithyroid drugs. Endocrinologist 1999;9(6):457-76. https://doi.org/10.1097/00019616-199911000-00008
  21. Park KH, Lee EJ. Recent review on medical treatment of thyroid disease. J Korean Med Assoc 2012;55(12):1207-14. https://doi.org/10.5124/jkma.2012.55.12.1207